T1	Participants 67 74	adults:
T2	Participants 226 274	adults at moderate and high risk for skin cancer
T3	Participants 284 417	Adults at moderate and high risk for skin cancer were recruited in primary health care settings in Honolulu, HI, and Long Island, NY.
T4	Participants 796 838	A total of 596 adults completed the trial.